NCT02951676

Brief Summary

This is a prospective, longitudinal, observational, cohort study investigating young adults undergoing surgical extraction of a wisdom tooth with and without antibiotics post-operatively. The prescription of antibiotics will be based on clinical judgment based on case complexity, trauma and length of procedure. No randomization will be performed. Saliva will be collected at seven observational time points ( Baseline, one week ,two weeks, three weeks , one month,three months and six months.) and Supragingival plaque samples will be collected at four observational time points ( Baseline , one week , one month, and 3 months) .A control group of 15 subjects who do not undergo dental extractions or antibiotic treatment will be recruited after obtaining informed consent and will be followed up for the same seven time points..Routine standard care will be observed. No new medications are triedThe samples will be analysed for identification of bacterial genes using 16 S r RNA gene sequecing and QPCR for change in the antibiotic resistance genes overtime. Kindly note that in the current study the participants are patients who are already scheduled to undergo tooth extractions with or without antibiotic treatment based on clinical judgement by the clinician performing the extraction. ( These patients are on the waiting list for third molar extractions in the dental hospital concerned.) The participants will receive the intervention( Third molar extraction with /without antibiotics) in the same manner and intensity even if they are not enrolled for the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
67

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2015

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 30, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 1, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

October 26, 2017

Status Verified

January 1, 2017

Enrollment Period

2.2 years

First QC Date

October 30, 2016

Last Update Submit

October 25, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Microbiome shift

    Baseline - Six months

Secondary Outcomes (2)

  • Antibiotic resistance genes count

    Baseline - One Month

  • levels of c reactive protein

    Baseline - One Month

Study Arms (3)

EA - Extraction with antibiotics

Patients undergoing third molar extraction with antibiotic treatment. Amoxicillin 250 mg , three times daily for five days.

Procedure: Extraction

E - Extraction without antibiotics

Patients undergoing third molar extraction with antibiotic treatment.

Procedure: Extraction

Control

Age and sex matched controls who are not undergoing extractions or antibiotic treatment

Interventions

ExtractionPROCEDURE

Extraction of impacted third molar teeth

E - Extraction without antibioticsEA - Extraction with antibiotics

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients on the waiting list of third molar extractions at the Prince Philip Dental Hospital, Hong Kong

You may qualify if:

  • Men and women aged between 18 and 45 years
  • Subjects who are scheduled to have a surgical tooth extraction.
  • Subjects who have signed an informed consent after being informed of the study design, objectives and, risks/benefits
  • No history of use of antibiotics up to three months prior to participation in the study. 5. No medical condition that prevents the surgical procedure or antibiotic therapy.
  • \. No history of hypersensitivity to beta lactams. 7. No contraindication to amoxicillin therapy. 8. Subjects are not pregnant or currently breast feeding. 9. No known or suspected immunodeficiency.

You may not qualify if:

  • History of antibiotic use within 3 months from baseline evaluation.
  • Any medical condition that prevents the surgical procedure or antibiotic therapy.
  • History of hypersensitivity to beta lactams
  • Contraindication for amoxicillin therapy
  • Pregnant or breast feeding women.
  • Subjects with known or suspected immunodeficiency.
  • Caries active subjects defined as subjects with active caries involving more than 3 teeth.
  • Subjects diagnosed with chronic periodontitis.
  • Subjects regularly using an antibacterial mouth rinse or planning to use one after the extraction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oral Rehabilitation, Faculty of Dentistry, The University of Hong Kong

Hong Kong, Guangdong, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

Saliva Supragingival plaque

Study Officials

  • Michael G Botelho, BDS,MsC,PhD

    Faculty of Dentistry, The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

October 30, 2016

First Posted

November 1, 2016

Study Start

December 1, 2015

Primary Completion

March 1, 2018

Study Completion

June 1, 2018

Last Updated

October 26, 2017

Record last verified: 2017-01

Locations